Archives

by in
Entry Author Date Location
Merck, Leapfrogging Bristol-Myers, Wins FDA Nod for Cancer Drug 09/04/14 New York
Celldex, Bristol-Myers Cut Deal on Immuno-Oncology Combo Trial 05/14/14 New York
Lightstone Closes $172M Fund for Early-Stage Biotechs 05/01/14 Boston
East Coast Biotech Roundup: Proteon, Ataxion, NY Genome/Watson, & More 03/21/14 Boston
Five Prime, Bristol-Myers Squibb Cut $350M Immuno-Oncology Deal 03/17/14 San Francisco
East Coast Biotech Roundup: Gerngross, Akili, Intercept, & More 01/10/14 Boston
Fresh from IPO, Five Prime Advances Arthritis and Cancer Drugs 12/19/13 San Francisco
Glaxo Setting Up San Diego Outpost to Oversee its Westward Expansion 11/25/13 San Diego
Acceleron Prices Upsized IPO at $15 Per Share, Begins Trading Thursday 09/19/13 Boston
Five Prime Therapeutics Obtains $62,400,000 New Financing Round 09/18/13 San Francisco
Five Prime Therapeutics Obtains $10,000,000 New Financing 04/20/12 San Francisco
FivePrime Nabs Partner, Solazyme’s $100M IPO Plan, Where Blockbuster Drugs Come From, & More Bay Area Life Sciences News 03/18/11 San Francisco
A Bidding War for 3Par, a Trademark War over Mafia Wars, a Barrage of New Y Combinator Startups, & More Bay Area BizTech and Life Sciences News 08/30/10 San Francisco
Five Prime Therapeutics, Gliding Like a Submarine, Quietly Takes Aim At Cancer 08/24/10 San Francisco
Corey Goodman’s New Startup, UCSF Spinoff Raises $40M, Gail Maderis Gives Back, & More Bay Area Life Sciences News 07/09/10 San Francisco
Gail Maderis, the Boston Biotech Exec Who Came Home to SF, Seeks to Give Back at BayBio 07/08/10 San Francisco
The Mission Bay Biotech Cluster: Antibodies, RNAi, Biofuels, & More 06/29/10 San Francisco
Five Prime Therapeutics Secures $40,282,000 New Funding 06/30/08 San Francisco
Page 1 of 1